What about ICD-11?
A delay for ICD-10 will not delay ICD-11
While the healthcare industry struggles with ICD-10 implementation, some are wondering what’s going to happen in 2017 when ICD-11 is released.
More than 100 countries use the classification system worldwide, and it’s been translated into 43 languages.
“Delaying ICD-10CM implementation, while disruptive and expensive to U.S. healthcare providers, would have no bearing on the ICD-11 timeline,” said Christopher G. Chute, MD, DrPH, of the Mayo Clinic, who is also the Chair of the ICD-11 Revision Steering Group, World Health Organization, in an email to MHE.
ICD-11 serves as a revision to ICD-10. Its features will include:
- A revision process that allows for collaborative web-based editing that open to all interested parties. To assure quality it will be peer reviewed for accuracy and relevance.
- It will be free to download online for personal use (and in print form for a fee).
- It will be available in multiple languages.
- Definitions, signs and symptoms, and other content related to diseases will be defined in a structured way so it can be recorded more accurately.
- It is compatible with electronic health applications and information systems.
Stakeholders and others interested can provide input to the beta version of ICD-11 using an online revision process. Peer-reviewed comments and input will be added through the revision period.
Watch the World Health Organization video invitation.
Chief Pharmacy Officer Jason R. Smith on the Challenges Health Systems Face
May 28th 2025Jason R. Smith, Pharm.D., appointed as chief pharmacy officer in February 2025 for the University of Rochester Medical Center, talks about building a stronger workforce, managing drug shortages and keeping up with changes in regulations because of the new administration.
Read More
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
